Gene and Cell Therapies (Pharmaceuticals, Health Economics and Market Access)

The major advances in the field of biotechnology and molecular biology in the 21st century has led to a better understanding of pathophysiology of diseases. A new generation of biopharmaceuticals has emerged including a wide and heterogeneous range of innovative therapies. These aim to prevent or treat chronic or serious life-threatening diseases, previously considered incurable. Gene and Cell Therapies: Market Access and Funding shows how the regulatory environment has evolved to analyse and review those therapies while HTA agencies and payers remain resistant. It provides insight into current learning, how those products will be accessible and which policy changes will be required to permit patient access. Key Features: Discusses the affordability of future therapy and the possible challenges for health insurance systems Highlights the gradual move from repeated treatment administration to one single administration with potential for a definite cure Describes the potential change of paradigm which will challenge all payers and may question the sustainability of our health care systems

• | Author: Eve Hanna|Mondher Toumi
• | Publisher: CRC Press
• | Publication Date: May 30, 2020
• | Number of Pages: 144 pages
• | Language: English
• | Binding: Paperback
• | ISBN-10: 0367408090
• | ISBN-13: 9780367408091